An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy - Quiz - MDSpire

An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy

  • By

  • Silvia Mihaela Ilie

  • Julie Lecuelle

  • François Ghiringhelli

  • Caroline Truntzer

  • Sylvain Ladoire

  • June 16, 2026

  • 0 min

Share

Original Source(s)

An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy

  • by Silvia Mihaela Ilie, Julie Lecuelle, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire

  • June 16, 2026

Related Content

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression

Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis

Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer